The pharmaceutical firm expects its workforce in Beijing to grow to 1,700 employees and is launching a JV with BioKangtai to ...

Investment includes agreements with Harbour BioMed, Syneron Bio and BioKangtai
.

Against the backdrop of global economic fragmentation and rising uncertainties, China reaffirmed its commitment to ...

Investing.com -- AstraZeneca (NASDAQ: AZN) Plc’s Chief Executive Officer, Pascal Soriot, has warned that Europe is rapidly losing its pharmaceutical innovation edge to China. He voiced his concerns ...

President Donald Trump continues to warn of tariffs on the pharmaceutical industry; Susan Monarez replaces Dave Weldon as CDC ...

The China Development Forum 2025 opened in Beijing on March 23, 2025. Photo: VCG. More than 30 years ago, when Jean-Pascal ...

The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...

Danish Prime Minister Mette Frederiksen pledged Tuesday that her government would resist what she called the unacceptable ...

The Trump administration has announced that the U.S. has come to agreements with both Ukraine and Russia about the ...

Chinese authorities released five local employees of U.S. consulting firm Mintz Group, two years after they were arrested at ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Chair Sir Sherard Cowper-Coles, President Lord Sassoon, Chief Executive Peter Burnett OBE and Managing Director, China, Tom ...